false
OasisLMS
Catalog
Traumatic Brain Injury PART FIVE: Initial 48 Hours
Video: TBI 5
Video: TBI 5
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In a recent webinar on traumatic brain injury (TBI) titled "The Initial 48 Hours," hosted by Kim Berry from the TCAA's Education Committee, Dr. Lena O'Keefe from Yale University School of Medicine shared her expertise on managing moderate to severe TBIs. Dr. O'Keefe, a neurointensivist, discussed initial assessment, case studies, and treatment guidelines based on current standards and practices, such as those from the Brain Trauma Foundation and Neurocritical Care Society. She highlighted the significance of early intervention and monitoring, emphasizing the need for potential surgical assessment, particularly in cases that present with specific conditions like epidural and subdural hematomas, as well as elevated intracranial pressure. <br /><br />Dr. O'Keefe also deliberated on the appropriate use of anti-seizure medications, such as Keppra, and considerations for anticoagulation reversal in patients on antiplatelet drugs. She addressed the role of Tranexamic Acid (TXA), particularly in mild to moderate TBI cases, and underscored the need for timely imaging and neurological assessments to guide treatment decisions.<br /><br />Particular emphasis was placed on maintaining systolic blood pressure and utilizing hyperosmolar therapies, sedation, and neuroprotection strategies to mitigate secondary brain injury. The session also touched on complex decision-making scenarios involving neurosurgical collaboration and the importance of comprehensive patient care in the critical early hours following a TBI. Dr. O'Keefe concluded by showcasing a positive outcome where proactive and methodical management significantly aided a patient's recovery, illustrating the potential for favorable prognoses even in severe cases.
Keywords
traumatic brain injury
Dr. Lena O'Keefe
initial assessment
Brain Trauma Foundation
epidural hematomas
intracranial pressure
anti-seizure medications
Tranexamic Acid
neuroprotection strategies
neurosurgical collaboration
×
Please select your language
1
English